Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

ImmunoMet Therapeutics

Request full access

And commercializes oncology products for cancer patients

Dexter, United StatesFounded 2016Biotech & Life Sciences

About ImmunoMet Therapeutics

ImmunoMet Therapeutics is a biotechnology company focused on developing innovative therapies by harnessing cellular metabolism. The company operates in the healthcare sector, specifically targeting metabolic reprogramming to treat fibrosis and oncology. ImmunoMet's business model revolves around research and development, with a strong emphasis on creating novel treatments that address unmet medical needs in these therapeutic areas. The company generates revenue through partnerships, licensing agreements, and securing funding from investors. ImmunoMet serves a diverse range of clients, including healthcare providers, research institutions, and pharmaceutical companies. The market it operates in is highly specialized, focusing on advanced medical treatments and biotechnological innovations. By leveraging cutting-edge research and strategic collaborations, ImmunoMet aims to bring transformative therapies to market, improving patient outcomes and advancing the field of medical science.

Source: Dealroom company data

At a glance

Founded
2016
Headquarters
Dexter, United States
Sector
Biotech & Life Sciences

ImmunoMet Therapeutics in the Dexter ecosystem

Live from Dealroom

The ImmunoMet Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Mirae Asset Venture Investment
  • NHN Investment
  • Sungwuk Kim
  • SL Investment
  • InterVest
  • G.N. Tech Venture
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about ImmunoMet Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ImmunoMet Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.